Pentoxifylline: Brief Review and Rationale for Its Possible Use in the Treatment of Autism

This publication has 25 references indexed in Scilit:

• Pentoxifylline inhibits experimental allergic encephalomyelitis
  Acta Neurologica Scandinavica, 2009
• Pentoxifylline inhibits tumor necrosis factor-α-mediated cytotoxicity and cytostasis in L929 murine fibrosarcoma cells
  International Journal of Immunopharmacology, 1994
• Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1‐ but not type 2‐associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats
  European Journal of Immunology, 1993
• IMMUNE RESPONSE MODULATION BY PENTOXIFYLLINE IN VITRO
  Transplantation, 1993
• Down-regulation of tumor necrosis factor expression by pentoxifylline in cancer patients: A pilot study
  Cancer Immunology, Immunotherapy, 1993
• Pentoxifylline Inhibits Certain Constitutive and Tumor Necrosis Factor-α-Induced Activities of Human Normal Dermal Fibroblasts
  Journal of Investigative Dermatology, 1992
• Cytokines in the central nervous system of mice during chronic relapsing experimental allergic encephalomyelitis
  Cellular Immunology, 1991
• An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis.
  The Journal of Experimental Medicine, 1990
• Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway.
  The Journal of Experimental Medicine, 1990
• Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro
  Annals of Neurology, 1988